Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    " July 22, 2009":" August 21, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" July 22, 2009":" August 21, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (35 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
2 Withdrawn Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts
Conditions: HIV Infection;   AIDS;   HIV Infections
Intervention:
3 Completed Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Behavioral: Tailored Information Program for Safer Sex
4 Completed Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
Condition: HIV Infections
Intervention: Drug: Etravirine (Intelence)
5 Completed Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men
Condition: HIV Infections
Interventions: Behavioral: Referral of Partners;   Behavioral: Screening for STIs and counseling;   Behavioral: Peer health care system navigators;   Behavioral: Enhanced counseling
6 Completed Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
7 Completed Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: efavirenz/emtricitabin/tenofovir;   Drug: lopinavir/ritonavir
8 Completed Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: maraviroc
9 Completed Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Lopinavir/ritonavir;   Drug: HAART;   Drug: Placebo
10 Active, not recruiting
Has Results
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: efavirenz
11 Active, not recruiting
Has Results
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572 (Cohort I);   Drug: GSK1349572 (Cohort II)
12 Unknown  Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection - A Positron Emission Tomography (PET) Study
Conditions: Acute Hepatitis C;   HIV;   HIV Infections
Intervention:
13 Completed Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT
Conditions: Insulin Resistance;   Atherosclerosis;   Cardiovascular Disease;   HIV/AIDS;   HIV Infections
Intervention:
14 Completed
Has Results
Reducing Sexual Risk Behaviors and Improving Health for People at a Sexually Transmitted Infection Clinic
Conditions: HIV;   Sexually Transmitted Diseases;   HIV Infections
Interventions: Behavioral: DVD 1;   Behavioral: DVD 2
15 Unknown  Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
Conditions: HIV Transmission;   HIV Infections
Intervention: Drug: tenofovir + emtricitabine, lopinavir/ritonavir
16 Completed Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Conditions: Herpes Simplex Type Two Infection;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
17 Completed Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults
Condition: HIV Infections
Interventions: Biological: NYVAC-B;   Biological: Placebo;   Biological: rAd5
18 Active, not recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
19 Recruiting Examining Benefits of HAART Continuation in Postpartum Mothers
Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
20 Completed
Has Results
A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)
Conditions: HIV Infections;   Hepatitis C;   HCV Infection
Interventions: Drug: PegIFN-2b;   Drug: RBV;   Drug: Placebo to Boceprevir;   Drug: Boceprevir

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years